| AstraZeneca PLC (AZN) |
GB |
$220.597B |
16.47 |
| Amgen Inc. (AMGN) |
US |
$159.618B |
14.30 |
| Bristol Myers Squibb Company (BMY) |
US |
$96.931B |
6.49 |
| CSL Limited Sponsored ADR (CSLLY) |
AU |
$76.680B |
0.00 |
| Alnylam Pharmaceuticals, Inc. (ALNY) |
US |
$42.998B |
0.00 |
| argenex SE (ARGX) |
NL |
$33.284B |
90.85 |
| BioNTech SE Sponsored ADR (BNTX) |
DE |
$26.025B |
0.00 |
| Biogen Inc. (BIIB) |
US |
$19.516B |
8.42 |
| BioMarin Pharmaceutical Inc. (BMRN) |
US |
$10.964B |
17.81 |
| Ascendis Pharma A/S (ASND) |
DK |
$10.582B |
0.00 |
| Swedish Orphan Biovitrum (BIOVF) |
SE |
$10.413B |
26.59 |
| Blueprint Medicines Corporation (BPMC) |
US |
$8.279B |
0.00 |
| Bio-Rad Laboratories, Inc. (BIO.B) |
US |
$6.805B |
23.68 |
| Axsome Therapeutics, Inc. (AXSM) |
US |
$5.116B |
0.00 |
| Alkermes plc (ALKS) |
IE |
$4.782B |
12.83 |
| CRISPR Therapeutics AG (CRSP) |
CH |
$4.462B |
0.00 |
| ADMA Biologics Inc (ADMA) |
US |
$4.331B |
32.39 |
| Akero Therapeutics, Inc. (AKRO) |
US |
$4.136B |
0.00 |
| Cytokinetics, Incorporated (CYTK) |
US |
$4.104B |
0.00 |
| Arcellx, Inc. (ACLX) |
US |
$3.656B |
0.00 |
| ACADIA Pharmaceuticals Inc. (ACAD) |
US |
$3.555B |
31.24 |
| Ascentage Pharma Group International - Unsponsored ADR (AAPG) |
CN |
$3.472B |
0.00 |
| Alvotech (ALVO) |
LU |
$2.692B |
15.40 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) |
US |
$2.334B |
0.00 |
| Apellis Pharmaceuticals, Inc. (APLS) |
US |
$2.240B |
0.00 |
| Bavarian Nordic (BVNRY) |
DK |
$2.089B |
11.04 |
| Agios Pharmaceuticals, Inc. (AGIO) |
US |
$2.047B |
0.00 |
| Apogee Therapeutics Inc. (APGE) |
US |
$2.041B |
0.00 |
| CG Oncology, Inc. (CGON) |
US |
$2.034B |
0.00 |
| Beam Therapeutics Inc. (BEAM) |
US |
$1.999B |
0.00 |
| Certara, Inc. (CERT) |
US |
$1.864B |
34.82 |
| Belite Bio, Inc. Sponsored ADR (BLTE) |
US |
$1.809B |
0.00 |
| Adaptive Biotechnologies Corporation (ADPT) |
US |
$1.744B |
0.00 |
| Arcutis Biotherapeutics, Inc. (ARQT) |
US |
$1.640B |
0.00 |
| Biohaven Ltd. (BHVN) |
US |
$1.507B |
0.00 |
| Celldex Therapeutics, Inc. (CLDX) |
US |
$1.468B |
0.00 |
| ANI Pharmaceuticals, Inc. (ANIP) |
US |
$1.413B |
14.56 |
| CureVac N.V. (CVAC) |
DE |
$1.211B |
5.87 |
| AbCellera Biologics Inc. (ABCL) |
CA |
$1.119B |
0.00 |
| Cidara Therapeutics, Inc. (CDTX) |
US |
$0.965B |
0.00 |
| BGM Group Ltd. (BGM) |
CN |
$0.949B |
0.00 |
| Anavex Life Sciences Corp. (AVXL) |
US |
$0.902B |
0.00 |
| Cogent Biosciences, Inc. (COGT) |
US |
$0.844B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
CH |
$0.808B |
0.00 |
| CorMedix Inc (CRMD) |
US |
$0.786B |
52.68 |
| ArriVent BioPharma, Inc. (AVBP) |
US |
$0.722B |
0.00 |
| AnaptysBio, Inc. (ANAB) |
US |
$0.702B |
0.00 |
| Autolus Therapeutics PLC Sponsored ADR (AUTL) |
GB |
$0.625B |
0.00 |
| Arbutus Biopharma Corporation (ABUS) |
US |
$0.611B |
0.00 |
| Castle Biosciences, Inc. (CSTL) |
US |
$0.578B |
39.24 |
| Arvinas, Inc. (ARVN) |
US |
$0.577B |
0.00 |
| Bicycle Therapeutics PLC Sponsored ADR (BCYC) |
GB |
$0.515B |
0.00 |
| Bicara Therapeutics Inc. (BCAX) |
US |
$0.502B |
0.00 |
| Celcuity, Inc. (CELC) |
US |
$0.494B |
0.00 |
| Abivax SA Sponsored ADR (ABVX) |
FR |
$0.492B |
0.00 |
| aTyr Pharma, Inc. (ATYR) |
US |
$0.470B |
0.00 |
| Cullinan Therapeutics, Inc. (CGEM) |
US |
$0.458B |
0.00 |
| Cytek Biosciences, Inc. (CTKB) |
US |
$0.457B |
0.00 |
| Citius Oncology, Inc. (CTOR) |
US |
$0.374B |
0.00 |
| Arcturus Therapeutics Holdings Inc. (ARCT) |
US |
$0.369B |
0.00 |
| Compass Therapeutics, Inc. (CMPX) |
US |
$0.362B |
0.00 |
| Amarin Corporation PLC (AMRN) |
IE |
$0.345B |
0.00 |
| Absci Corporation (ABSI) |
US |
$0.343B |
0.00 |
| Benitec Biopharma Limited (BNTC) |
US |
$0.334B |
0.00 |
| Aura Biosciences, Inc. (AURA) |
US |
$0.325B |
0.00 |
| Astria Therapeutics, Inc. (ATXS) |
US |
$0.323B |
0.00 |
| Atea Pharmaceuticals, Inc. (AVIR) |
US |
$0.310B |
0.00 |
| Annexon, Inc. (ANNX) |
US |
$0.308B |
0.00 |
| Crescent Biopharma, Inc. (CBIO) |
US |
$0.304B |
0.00 |
| Abeona Therapeutics Inc. (ABEO) |
US |
$0.300B |
0.00 |
| Aardvark Therapeutics, Inc. (AARD) |
US |
$0.293B |
0.00 |
| ADC Therapeutics SA (ADCT) |
CH |
$0.278B |
0.00 |
| Corvus Pharmaceuticals, Inc. (CRVS) |
US |
$0.271B |
0.00 |
| Allogene Therapeutics, Inc. (ALLO) |
US |
$0.262B |
0.00 |
| Candel Therapeutics, Inc. (CADL) |
US |
$0.250B |
0.00 |
| Cardiff Oncology, Inc. (CRDF) |
US |
$0.239B |
0.00 |
| Codexis, Inc. (CDXS) |
US |
$0.233B |
0.00 |
| Adocia (ADOCY) |
FR |
$0.216B |
0.00 |
| CARGO Therapeutics, Inc. (CRGX) |
US |
$0.203B |
0.00 |
| AC Immune (ACIU) |
CH |
$0.203B |
0.00 |
| BioStem Technologies, Inc. (BSEM) |
|
$0.201B |
8.16 |
| CytomX Therapeutics, Inc. (CTMX) |
US |
$0.200B |
5.17 |
| Alumis Inc. (ALMS) |
US |
$0.178B |
0.00 |
| Alpha Cognition Inc. (ACOG) |
CA |
$0.171B |
0.00 |
| Anika Therapeutics Inc. (ANIK) |
US |
$0.161B |
0.00 |
| Compugen Ltd. (CGEN) |
IL |
$0.155B |
0.00 |
| BioAge Labs, Inc. (BIOA) |
US |
$0.152B |
0.00 |
| Agenus Inc. (AGEN) |
US |
$0.151B |
0.00 |
| Alector, Inc. (ALEC) |
US |
$0.150B |
0.00 |
| Black Diamond Therapeutics, Inc. (BDTX) |
US |
$0.148B |
43.33 |
| Cuprina Holdings (Cayman) Limited (CUPR) |
SG |
$0.140B |
0.00 |
| Actuate Therapeutics, Inc. (ACTU) |
US |
$0.132B |
0.00 |
| Caribou Biosciences, Inc. (CRBU) |
US |
$0.127B |
0.00 |
| BioHarvest Sciences Inc. (BHST) |
CA |
$0.112B |
0.00 |
| C4 Therapeutics, Inc. (CCCC) |
US |
$0.108B |
0.00 |
| Contineum Therapeutics, Inc. (CTNM) |
US |
$0.103B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
US |
$0.103B |
0.00 |
| Coya Therapeutics, Inc. (COYA) |
US |
$0.097B |
0.00 |
| BeyondSpring Inc. (BYSI) |
US |
$0.092B |
0.00 |
| Coherus Oncology, Inc. (CHRS) |
US |
$0.092B |
0.00 |
| Cellectis S.A. (CLLS) |
FR |
$0.092B |
0.00 |
| Climb Bio, Inc. (CLYM) |
US |
$0.085B |
0.00 |
| Cabaletta Bio, Inc. (CABA) |
US |
$0.081B |
0.00 |
| Anebulo Pharmaceuticals, Inc. (ANEB) |
US |
$0.074B |
0.00 |
| Acumen Pharmaceuticals, Inc. (ABOS) |
US |
$0.068B |
0.00 |
| Akoya Biosciences, Inc. (AKYA) |
US |
$0.067B |
0.00 |
| Adaptimmune Therapeutics PLC (ADAP) |
GB |
$0.064B |
0.00 |
| Clearside Biomedical, Inc. (CLSD) |
US |
$0.063B |
0.00 |
| Alto Neuroscience, Inc. (ANRO) |
US |
$0.062B |
0.00 |
| Biomea Fusion, Inc. (BMEA) |
US |
$0.062B |
0.00 |
| Connect Biopharma Holdings Limited Sponsored ADR (CNTB) |
US |
$0.060B |
0.00 |
| Adlai Nortye Ltd. Sponsored ADR (ANL) |
KY |
$0.056B |
0.00 |
| ABVC BioPharma, Inc. (ABVC) |
US |
$0.053B |
0.00 |
| Cue Biopharma, Inc. (CUE) |
US |
$0.052B |
0.00 |
| Adicet Bio, Inc. (ACET) |
US |
$0.051B |
0.00 |
| Atara Biotherapeutics, Inc. (ATRA) |
US |
$0.049B |
0.00 |
| Celularity, Inc. (CELU) |
US |
$0.049B |
0.00 |
| CervoMed Inc. (CRVO) |
US |
$0.048B |
0.00 |
| Applied Therapeutics Inc. (APLT) |
US |
$0.048B |
0.00 |
| Adverum Biotechnologies, Inc. (ADVM) |
US |
$0.047B |
0.00 |
| Annovis Bio, Inc. (ANVS) |
US |
$0.046B |
0.00 |
| Aligos Therapeutics, Inc. (ALGS) |
US |
$0.045B |
0.00 |
| Artiva Biotherapeutics, Inc. (ARTV) |
US |
$0.039B |
0.00 |
| Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) |
GB |
$0.038B |
0.00 |
| Akari Therapeutics PLC (AKTX) |
GB |
$0.037B |
0.00 |
| Alterity Therapeutics Limited - Sponsored ADR (ATHE) |
AU |
$0.036B |
0.00 |
| Clene Inc. (CLNN) |
US |
$0.035B |
0.00 |
| AN2 Therapeutics, Inc. (ANTX) |
US |
$0.033B |
0.00 |
| Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) |
GB |
$0.032B |
0.00 |
| CAMP4 Therapeutics Corporation (CAMP) |
US |
$0.027B |
0.00 |
| Coeptis Therapeutics Holdings, Inc. (COEP) |
US |
$0.026B |
0.00 |
| Cadrenal Therapeutics, Inc. (CVKD) |
US |
$0.024B |
0.00 |
| ALX Oncology Holdings Inc. (ALXO) |
US |
$0.024B |
0.00 |
| Boundless Bio, Inc. (BOLD) |
US |
$0.024B |
0.00 |
| BioAtla, Inc. (BCAB) |
US |
$0.023B |
0.00 |
| CalciMedica Inc. (CALC) |
US |
$0.022B |
0.00 |
| Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) |
IL |
$0.022B |
0.00 |
| Cognition Therapeutics, Inc. (CGTX) |
US |
$0.021B |
0.00 |
| Aytu BioPharma Inc. (AYTU) |
US |
$0.021B |
0.00 |
| BRIACELL THERAP (BCTX) |
CA |
$0.020B |
0.00 |
| Cingulate Inc. (CING) |
US |
$0.018B |
0.00 |
| Curis, Inc. (CRIS) |
US |
$0.018B |
0.00 |
| CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) |
IL |
$0.018B |
0.00 |
| Advanced Biomed Inc. (ADVB) |
US |
$0.015B |
0.00 |
| Allarity Therapeutics, Inc. (ALLR) |
US |
$0.015B |
0.00 |
| Aspire Biopharma Holdings, Inc. (ASBP) |
US |
$0.014B |
0.00 |
| Biorestorative Therapies, Inc. (BRTX) |
US |
$0.012B |
0.00 |
| Athira Pharma, Inc. (ATHA) |
US |
$0.012B |
0.00 |
| Abpro Holdings Inc. (ABP) |
US |
$0.012B |
0.00 |
| BioXcel Therapeutics, Inc. (BTAI) |
US |
$0.012B |
0.00 |
| Brainstorm Cell Therapeutics Inc. (BCLI) |
US |
$0.012B |
0.00 |
| Bionano Genomics, Inc. (BNGO) |
US |
$0.011B |
0.00 |
| Acurx Pharmaceuticals, Inc. (ACXP) |
US |
$0.011B |
0.00 |
| Bolt Biotherapeutics, Inc. (BOLT) |
US |
$0.011B |
0.00 |
| BioCardia, Inc. (BCDA) |
US |
$0.011B |
0.00 |
| COSCIENS Biopharma Inc. (CSCI) |
CA |
$0.011B |
0.00 |
| Cyclerion Therapeutics, Inc. (CYCN) |
US |
$0.011B |
0.00 |
| Aprea Therapeutics, Inc. (APRE) |
US |
$0.009B |
0.00 |
| bioAffinity Technologies, Inc. (BIAF) |
US |
$0.008B |
0.00 |
| Apollomics Inc. (APLM) |
US |
$0.007B |
0.00 |
| Creative Medical Technology Holdings, Inc. (CELZ) |
US |
$0.007B |
0.00 |
| Biofrontera Inc. (BFRI) |
US |
$0.007B |
0.00 |
| Cardio Diagnostics Holdings, Inc. (CDIO) |
US |
$0.006B |
0.00 |
| Artelo Biosciences, Inc. (ARTL) |
US |
$0.006B |
0.00 |
| Cyclacel Pharmaceuticals, Inc. (CYCC) |
|
$0.006B |
0.00 |
| 180 Life Sciences Corp. (ATNF) |
US |
$0.005B |
0.00 |
| Avalon GloboCare Corp. (ALBT) |
US |
$0.005B |
0.00 |
| CNS Pharmaceuticals, Inc. (CNSP) |
US |
$0.005B |
0.00 |
| Adial Pharmaceuticals, Inc. (ADIL) |
US |
$0.003B |
0.00 |
| AquaBounty Technologies, Inc. (AQB) |
US |
$0.003B |
0.00 |
| Alzamend Neuro, Inc. (ALZN) |
US |
$0.002B |
0.00 |
| Aptevo Therapeutics Inc. (APVO) |
US |
$0.002B |
0.00 |
| Bone Biologics Corp. (BBLG) |
US |
$0.002B |
0.00 |
| Aceragen, Inc. (ACGN) |
US |
$0.000B |
0.00 |
| ARAVIVE, INC (ARAV) |
US |
$0.000B |
0.00 |
| Clovis Oncology, Inc. (CLVSQ) |
US |
$0.000B |
0.00 |
| Cocrystal Pharma, Inc. (COCP) |
US |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
BE |
$0.000B |
0.00 |
